| Completed | A Study to Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Healthy | Phase 3 | 2015-09-21 |
| Completed | A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in He Respiratory Syncytial Viruses, Respiratory Tract Infections | Phase 1 | 2015-09-01 |
| Completed | A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV Healthy Participants | Phase 1 | 2015-04-21 |
| Completed | A Study to Assess the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Healthy | Phase 1 | 2015-04-01 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Health Healthy | Phase 1 | 2015-03-01 |
| Completed | A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants Healthy | Phase 1 | 2014-12-17 |
| Completed | Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Healthy | Phase 1 | 2014-12-01 |
| Completed | A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults Healthy | Phase 1 | 2014-09-23 |
| Completed | Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults Influenza | Phase 1 | 2014-05-01 |
| Withdrawn | Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection Influenza | Phase 2 | 2013-12-01 |
| Completed | Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge Influenza | Phase 2 | 2013-10-02 |
| Completed | A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject Diphtheria, Pertussis, Tetanus | Phase 3 | 2013-09-01 |
| Completed | Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14) Influenza | Phase 3 | 2013-07-01 |
| Completed | Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus Influenza | Phase 1 | 2013-02-01 |
| Completed | Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses Influenza | Phase 1 | 2013-01-01 |
| Completed | Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients Influenza | — | 2012-12-01 |
| Completed | Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains Influenza | N/A | 2012-07-01 |
| Completed | Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains Influenza | Phase 3 | 2012-07-01 |
| Completed | Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine Influenza | Phase 1 | 2012-06-01 |
| Completed | Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Po Rabies | Phase 2 | 2011-12-01 |
| Completed | A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Para Influenza | Phase 4 | 2011-10-01 |
| Completed | Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From T Influenza | Phase 3 | 2011-10-01 |
| Completed | A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Eff Malaria | Phase 1 / Phase 2 | 2011-06-01 |
| Completed | Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in N Hepatitis B | Phase 3 | 2011-05-01 |
| Completed | Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vac Diphtheria, Pertussis, Tetanus | Phase 4 | 2011-05-01 |
| Completed | Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V Influenza | Phase 3 | 2010-10-01 |
| Completed | Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From T Influenza | Phase 3 | 2010-10-01 |
| Completed | A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Influenza | Phase 4 | 2010-06-01 |
| Completed | Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Diphtheria, Pertussis, Tetanus | Phase 3 | 2010-04-01 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Chi Hepatitis A | Phase 4 | 2010-03-01 |
| Completed | Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children Influenza | Phase 3 | 2009-10-01 |
| Completed | A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Influenza | Phase 4 | 2009-06-01 |
| Completed | A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Influenza | Phase 4 | 2008-07-01 |
| Completed | Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Rabies | Phase 2 | 2008-05-01 |
| Completed | A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabie Rabies | Phase 2 | 2008-03-01 |
| Completed | Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered W Hepatitis A | Phase 3 | 2007-03-14 |
| Completed | Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine Hepatitis A | Phase 2 | 2004-06-01 |